Showing results (1641-1650 of 2,519) with videos related to

Sort By:
Pageof 252
The Journal of Allergy and Clinical Immunology|May 1, 2012
Comparative dietary therapy effectiveness in remission of pediatric eosinophilic esophagitisCarol J Henderson, J Pablo Abonia, Eileen C King, et al.
Gastroenterology|August 1, 2017
Pathophysiology of Eosinophilic EsophagitisKelly M O'Shea, Seema S Aceves, Evan S Dellon, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|April 4, 2008
Eosinophils: biological properties and role in health and diseaseSimon P Hogan, Helene F Rosenberg, Redwan Moqbel, et al.
Clinical Pharmacology and Therapeutics|February 14, 2015
The role of nonrandomized trials in the evaluation of oncology drugsR Simon, G M Blumenthal, M L Rothenberg, et al.
Development and Psychopathology|June 25, 2019
Social network isolation mediates associations between risky symptoms and substance use in the high school transitionAndrea M Hussong, Susan T Ennett, Daniel M McNeish, et al.
The Journal of Allergy and Clinical Immunology|December 28, 2023
Persistent esophageal changes after histologic remission in eosinophilic esophagitisMelanie A Ruffner, Tetsuo Shoda, Megha Lal, et al.
Clinical Nutrition (Edinburgh, Scotland)|February 24, 2026
Phenotype profiling of disease-related malnutrition with inflammation: Document elaborated by the ESPEN special interest group (SIG) ''cachexia-anorexia in chronic wasting diseases''Alessio Molfino, Giovanni Imbimbo, Elisabet Rothenberg, et al.
Techniques in Urology|May 8, 2000
Treatment of extraprostatic cancer in clinically organ-confined prostate cancer by permanent interstitial brachytherapy: is extraprostatic seed placement necessary?B J Davis, M G Haddock, T M Wilson, et al.
Regenerative Medicine|February 3, 2021
Pain and functional outcomes of the sacroiliac joint after platelet-rich plasma injection: a descriptive reviewJoshua B Rothenberg, Keshav Godha, David M Civitarese, et al.
The Journal of Clinical Investigation|February 5, 2011
A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinomaBenjamin Ory, Matthew R Ramsey, Catherine Wilson, et al.
Pageof 252